PAUSHAK LIMITED (PAUSHAKLTD) financials
PAUSHAK LIMITED (PAUSHAKLTD) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Paushak is India’s largest phosgene based specialty chemicals manufacturer serving pharmaceutical, agrochemical and performance industries. Paushak is part of the Alembic group of companies situated in Gujarat, India.. Alembic Ltd is the oldest pharmaceutical company in India founded in 1907.[1][2]
- Market Cap: ₹1,598Cr.
- Current Price: ₹648
- Stock P/E: 33.8
- ROE: 6.98%
- ROCE: 8.30%
- Book Value: ₹210
- Dividend Yield: 0.39%
- 52W High / Low: ₹882/342
In Sep 2026, PAUSHAK LIMITED (PAUSHAKLTD) reported sales ₹89 Cr and net profit ₹14 Cr.
Annual TTM: sales ₹277 Cr, net profit ₹47 Cr.
Shareholding: Promoters 67.28% (Sep 2026), FIIs 0.11% (Sep 2026), DIIs 0.27% (Sep 2026), Public 32.35% (Sep 2026), No. of Shareholders 20,725% (Sep 2026).
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 49 | 52 | 56 | 59 | 49 | 55 | 84 | 89 |
| Expenses | 35 | 36 | 38 | 44 | 37 | 38 | 58 | 63 |
| Operating Profit | 15 | 16 | 18 | 15 | 11 | 17 | 26 | 26 |
| OPM % | 30% | 30% | 32% | 25% | 23% | 30% | 31% | 30% |
| Other Income | 6 | 0 | 2 | 1 | 1 | 8 | 3 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Depreciation | 4 | 4 | 4 | 4 | 5 | 8 | 8 | 8 |
| Profit before tax | 17 | 12 | 16 | 11 | 7 | 16 | 19 | 19 |
| Tax % | 11% | 21% | 23% | 24% | 17% | 22% | 21% | 27% |
| Net Profit | 15 | 10 | 12 | 9 | 6 | 13 | 15 | 14 |
| EPS in Rs | 6.20 | 3.90 | 4.89 | 3.50 | 2.50 | 5.07 | 6.12 | 5.48 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 138 | 141 | 150 | 212 | 206 | 211 | 219 | 277 |
| Expenses | 95 | 91 | 96 | 137 | 142 | 151 | 158 | 197 |
| Operating Profit | 43 | 50 | 54 | 75 | 65 | 60 | 61 | 80 |
| OPM % | 31% | 36% | 36% | 35% | 31% | 28% | 28% | 29% |
| Other Income | 7 | 6 | 5 | 11 | 20 | 14 | 12 | 14 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 4 |
| Depreciation | 4 | 5 | 9 | 13 | 14 | 15 | 21 | 30 |
| Profit before tax | 45 | 52 | 50 | 72 | 71 | 59 | 50 | 61 |
| Tax % | 23% | 28% | 25% | 25% | 23% | 16% | 22% | — |
| Net Profit | 35 | 37 | 38 | 54 | 54 | 49 | 39 | 47 |
| EPS in Rs | 14.19 | 15.16 | 15.29 | 21.96 | 22.09 | 20.07 | 15.95 | 19.17 |
| Dividend Payout % | 5% | 5% | 10% | 10% | 11% | 12% | 16% | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 12 | 12 |
| Reserves | 224 | 269 | 302 | 351 | 405 | 462 | 479 | 504 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 25 | 77 | 68 |
| Other Liabilities | 43 | 57 | 61 | 61 | 73 | 81 | 92 | 100 |
| Total Liabilities | 270 | 329 | 367 | 415 | 481 | 572 | 660 | 684 |
| Fixed Assets | 41 | 51 | 147 | 149 | 152 | 141 | 377 | 375 |
| CWIP | 16 | 68 | 8 | 7 | 29 | 190 | 26 | 16 |
| Investments | 163 | 154 | 151 | 182 | 223 | 139 | 150 | 168 |
| Other Assets | 50 | 56 | 61 | 78 | 77 | 102 | 107 | 126 |
| Total Assets | 270 | 329 | 367 | 415 | 481 | 572 | 660 | 684 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 24 | 41 | 30 | 44 | 43 | 56 | 38 | 54 |
| Cash from Investing Activity | -0 | -39 | -29 | -42 | -38 | -50 | -57 | -95 |
| Cash from Financing Activity | -23 | -2 | -2 | -2 | -4 | -5 | 19 | 42 |
| Net Cash Flow | 0 | 0 | -1 | -0 | 0 | 0 | -1 | 0 |
| Free Cash Flow | 13 | 27 | -26 | -4 | 28 | 17 | -122 | -34 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 85% | 116% | 85% | 98% | 73% | 107% | 82% | 97% |
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 66.97% | 67.14% | 67.14% | 67.28% | 67.28% | 67.28% | 67.28% | 67.28% |
| FIIs | 0.00% | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.11% |
| DIIs | 0.39% | 0.53% | 0.53% | 0.70% | 0.67% | 0.25% | 0.06% | 0.27% |
| Public | 32.64% | 32.33% | 32.34% | 32.02% | 32.05% | 32.48% | 32.66% | 32.35% |
| No. of Shareholders | 20,748 | 20,286 | 20,175 | 22,013 | 21,737 | 21,419 | 21,399 | 20,725 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 85 | 69 | 85 | 97 | 90 | 90 | 94 | 92 |
| Inventory Days | 122 | 131 | 148 | 233 | 180 | 177 | 179 | 292 |
| Days Payable | 73 | 110 | 118 | 227 | 122 | 130 | 167 | 245 |
| Cash Conversion Cycle | 133 | 89 | 115 | 103 | 149 | 137 | 107 | 139 |
| Working Capital Days | 100 | 75 | 60 | 81 | 93 | 84 | 80 | 64 |
| ROCE % | 27% | 21% | 20% | 17% | 21% | 17% | 11% | 8% |
Paushak Limited
₹1,598Cr.
₹648
₹882/342
33.8
Paushak is India’s largest phosgene based specialty chemicals manufacturer serving pharmaceutical, agrochemical and performance industries. Paushak is part of the Alembic group of companies situated in Gujarat, India.. Alembic Ltd is the oldest pharmaceutical company in India founded in 1907.[1][2]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of PAUSHAK LIMITED (PAUSHAKLTD)?
The reported market capitalisation for PAUSHAK LIMITED (PAUSHAKLTD) is ₹1,598Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of PAUSHAKLTD?
The current price shown for PAUSHAK LIMITED (PAUSHAKLTD) on Fincrux is ₹648 with a 52-week high/low of ₹882/342.
What is the P/E ratio of PAUSHAK LIMITED (PAUSHAKLTD)?
The stock P/E for PAUSHAK LIMITED (PAUSHAKLTD) is 33.8 on Fincrux, with ROE at 6.98% and ROCE at 8.30%.
What were PAUSHAKLTD latest quarterly results?
For Sep 2026, PAUSHAK LIMITED (PAUSHAKLTD) reported sales ₹89 Cr and net profit ₹14 Cr (figures in ₹ crore unless noted).
What are PAUSHAKLTD annual sales and net profit?
For TTM, PAUSHAK LIMITED (PAUSHAKLTD) shows sales of ₹277 Cr and net profit of ₹47 Cr on the Fincrux profit & loss statement.
Who owns PAUSHAK LIMITED (PAUSHAKLTD)?
Latest shareholding for PAUSHAK LIMITED (PAUSHAKLTD) on Fincrux: Promoters 67.28% (Sep 2026), FIIs 0.11% (Sep 2026), DIIs 0.27% (Sep 2026), Public 32.35% (Sep 2026), No. of Shareholders 20,725% (Sep 2026).
Where can I find PAUSHAK LIMITED (PAUSHAKLTD) financials?
PAUSHAK LIMITED (PAUSHAKLTD) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show PAUSHAKLTD balance sheet and cash flow?
Yes. The PAUSHAK LIMITED (PAUSHAKLTD) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.